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Background: Preterm birth is a major determinant of neonatal survival andmorbidity, but
the gut microbiome and associated enteric inflammation are also key factors in neonatal
development and the risk of associated morbidities. We prospectively and longitudinally
followed two cohorts of preterm infants, one of which was fed activated Bifidobacterium
longum subsp. infantis (B. infantis) EVC001 8 × 109 CFU daily, and the other was not
fed a probiotic. Hospital feeding protocol assigned all infants born at <1500 g and/or
<32 weeks corrected gestational age to the probiotic feeding protocol, whereas infants
born at >1500 g and/or >32 weeks corrected gestational age were not fed a probiotic.
Fecal samples were opportunistically collected from 77 infants throughout the hospital
stay, and subjected to shotgun metagenomic sequencing and quantification of enteric
inflammation. De-identified metadata was collected from patient medical records.
Results: The gut microbiome of preterm infants was typified by a high abundance
of Enterobacteriaceae and/or Staphylococcaceae, and multivariate modeling identified
the probiotic intervention, rather than degree of prematurity, day of life, or other clinical
interventions, as the primary source of change in the gut microbiome. Among infants fed
B. infantis EVC001, a high abundance of total Bifidobacteriaceae developed rapidly, the
majority of which was B. infantis confirmed via subspecies-specific qPCR. Associated
with this higher abundance of Bifidobacteriaceae, we found increased functional capacity
for utilization of human milk oligosaccharides (HMOs), as well as reduced abundance of
antibiotic resistance genes (ARGs) and the taxa that harbored them. Importantly, we
found that infants fed B. infantis EVC001 exhibited diminished enteric inflammation,
even when other clinical variables were accounted for using multivariate modeling.
Nguyen et al. Microbiome Modulation in Premature Infants
Conclusion: These results provide an important observational background for probiotic
use in a NICU setting, and describe the clinical, physiological, and microbiome-
associated improvements in preterm infants associated with B. infantis EVC001 feeding.
Keywords: preterm infant, gutmicrobiome, enteric inflammation, antibiotic resistant genes (ARG),Bifidobacterium
longum subspecies infantis EVC001
INTRODUCTION
Preterm birth, defined as <37 weeks gestation age, accounts for
over 1 in 10 live births in the United States and is associated
with an immature gastrointestinal tract, diminished gut barrier
function, and underdeveloped immune function leading to
increased morbidity and mortality compared to term infants
(1–3). Unlike infants born at full-term, premature infants have
extended stays in the hospital environment of the Neonatal
Intensive Care Unit (NICU), increased exposure to associated
clinical protocols including antibiotics, proton pump inhibitors,
parenteral nutrition, and limited access to human milk, all of
which dramatically shapes gut microbiome composition (4, 5).
Importantly, recent work has shown that preterm infants are
rapidly colonized by nosocomial, antibiotic-resistant bacteria
associated with an increased risk of serious infection and death
(6). These bacteria confer negative impacts on neonatal growth
and development (4) and are associated with an increased risk
of necrotizing enterocolitis (NEC) (7, 8) and late-onset sepsis
(9–11). Importantly, increased prevalence of Proteobacteria
has been shown to precede NEC (7, 11, 12) and exacerbate
enteric inflammation (13). Proteobacteria, broadly, have also
been associated with the pathogenesis of sepsis and NEC in
premature infants (14–16). Although the exact mechanisms by
which these bacteria evoke heightened inflammatory responses
in the preterm infant gut are not completely understood,
suboptimal mucosal integrity and/or predisposition toward an
exaggerated inflammatory profile, including exacerbated IL-8
cytokine production, has been observed in preterm infants
(17). Indeed, exaggerated inflammatory responses driven by
nosocomially derived microbes including Proteobacteria have led
to a desire to find strategies, including the use of probiotics,
to mitigate the risks associated with prematurity that have
etiological links to the gut microbiome.
A recent observational study comparing longitudinal
fecal samples taken from preterm infants showed that
supplementation with Bifidobacterium and Lactobacillus
remodeled the gut microbiome, replicating a gut microbiome
more closely resembling that of a term infant. However,
physiological effects on the host were not determined (18),
and distinct species-specific effects among Bifidobacterium
are beginning to emerge that distinguish the ability among
Bifidobacterium species to modulate host enteric inflammation
and epithelial integrity from those that do not (19, 20). Beyond
observational studies, extensive evidence has indicated a
beneficial role of feeding Bifidobacterium longum subsp. infantis
(B. infantis) to premature infants, with significant decreases
in morbidity and mortality reported, including those from
NEC (21–23). In animal models, B. infantis supplementation
was effective at reducing NEC injury scores and minimizing
intestinal inflammation (24, 25). Furthermore, establishing
B. infantis abundance in the infant gut restores important
ecosystem services of the microbiome that are beneficial to
infant health (26). Particularly, the efficient fermentation of
human milk oligosaccharides (HMOs) into host-accessible
organic acids (e.g., acetate and lactate) helps reduce degradation
of gastrointestinal mucin, and results in significant reductions
of bacterial populations with pathogenic potential (19, 26–29).
Moreover, when B. infantis is compared directly to other
probiotic bacteria, including Bifidobacterium animalis subsp.
lactis (B. lactis), it showed superior ability to colonize the
premature infant gut (30), based on its ability to utilize the full
suite of selective prebiotic carbohydrates found in human milk
(HMOs). Therefore, early establishment of a gut microbiome
that limits growth of bacteria associated with detrimental
outcomes, maximizes nutrition, and reduces inflammation
during a key developmental window is particularly important to
preterm neonatal health.
To examine the effect of feeding B. infantis EVC001 to a
preterm infant population, we prospectively and longitudinally
collected fecal samples from 77 infants born before 37 weeks
postmenstrual age and compared the gut microbial composition
and development, as well as enteric inflammation profiles.
These infants were assigned to one of two distinct, hospital-
directed feeding protocols based on gestational age at birth and
weight at birth. One feeding protocol dictating daily feedings
of B. infantis EVC001 (EVC001-fed; < 32 weeks corrected
gestational age and/or < 1500 grams; n = 31) and a second
feeding protocol were used for premature infants born after
32 weeks corrected gestational age and > 1500 g at birth (“No
probiotic”; n = 46; Figure 1A). All infants were predominantly
fed human milk but were discordant for probiotic use based on
their corrected gestational age. Further, we collected deidentified
patient metadata to compare the impact of other clinical
interventions on the preterm infant gut microbiome and to
account for known differences between the feeding cohorts.
Here, we find that EVC001-fed premature infants had increased
colonization of Bifidobacterium in their gut microbiome, an
increase in genes conferring efficient utilization of HMOs,
significantly decreased overall abundance of antibiotic-resistant
(bacterial) genomes (ARGs), and importantly, a decreased
enteric inflammatory profile compared to premature infants
not fed a probiotic, after accounting for other confounding
clinical variables.
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FIGURE 1 | Sample collection and general sample microbiome composition. (A) The general study design is outlined describing the patient cohorts, per hospital
feeding protocol, and prospective fecal sampling. Infants born in two hospitals were enrolled shortly after birth and, per hospital protocol, assigned to a feeding
protocol based on gestational age at birth and weight at birth. Infants born at >32 weeks corrected gestational age (cGA) and 1500g were assigned to a feeding
(Continued)
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FIGURE 1 | protocol which did not include a probiotic (gray, top). Infants born at <32 weeks cGA and/or <1500g were assigned to a feeding protocol which included
daily feedings of B. longum subsp. infantis EVC001 (8 × 109 CFU once per day) starting with the initiation of trophic feeding (teal, bottom) and delivered in a single
serving of 0.5mL medium chain triglyceride oil. Nurses collected fecal samples (brown circles) opportunistically throughout the patient’s stay in the neonatal intensive
care unit (NICU), aiming for two or more samples per week. Infants received human milk (maternal or donor) through 34 weeks corrected gestational age, as well as
human milk-based human milk fortifier. After 34 weeks, infant formula was used in addition to human milk. (B) Shotgun metagenome sequencing performed on
samples collected from all 77 infants was used to classify the average community structure of the infant microbiome in all samples. Individual sample compositions
were generally similar and typified by either: (C) a high abundance of Bifidobacterium longum species (inclusive of B. longum subsp. infantis; Bifidobacteriaceae, blue),
(D) a high abundance of Staphylococcus epidermidis (Staphylococcaceae, gray) and Enterobacteriaceae (red), or (E) an overwhelming abundance of Escherichia coli
and unclassified Escherichia (Enterobacteriaceae, red).
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test
Fecal sample collected, n: 104 193
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14 (13.5) 10 (5.2) 0.024 Fisher’s exact
test
Steroid use coinciding
with sampling, n (%)
1 (0.96) 43
(22.28)
< 0.001 Fisher’s exact
test
Fecal sample sequencing
passing quality filter, n (%)
101 (97) 191 (99)
Fecal sample inflammatory
quantification, n (%)
83 (80) 171 (89)
RESULTS
Demographics and Clinical Observations
of the Preterm Infant Subjects
Seventy-seven [77] preterm infants were enrolled from May to
October 2019 from Kaiser Permanente Orange County Anaheim
Medical Center (Anaheim, CA USA; Level 3 NICU, 25 beds)
and Kaiser Permanente Orange County Irvine Medical Center
(Irvine, CA USA; Level 2 NICU, 10 beds). No changes to the
hospital standard of care were introduced by participation in this
prospective sampling study. Participant demographic and clinical
data are provided in Table 1. Per hospital feeding protocols,
infants born at <32 weeks gestational age (GA) or at <1500
grams birth weight received B. infantis EVC001 with MCT oil,
via orogastric or nasogastric tube starting at the initiation of
trophic feeds and continued daily through 34 weeks corrected
gestational age (cGA, n = 31). Infants born after 32 weeks GA
did not receive B. infantis EVC001 or any other probiotic (n =
46; Figure 1A). Thus, the two study groups differed in general
clinical acuity, in both feeding protocols and the level of acuity
between hospitals. Given the differences in gestational age (P
< 0.001), there was also a corresponding difference in birth
weight (P < 0.001), but both groups received a predominantly
human milk diet via maternal, donor, and/or commercial human
milk through 34 weeks cGA and the infants born at an older
GA not fed probiotics received more infant formula as a result
(P < 0.001). Also, significantly more fecal samples were collected
from the infants fed B. infantis EVC001 compared to infants
not fed probiotics [6.23 vs. 2.26 on average, P < 0.001] due to
the generally longer duration of stay of the infants born more
premature, and infants born at an earlier gestational age received
more inhaled steroids, owing to their prematurity (e.g., albuterol,
budesonide, levalbuterol, ipratropium; 22 vs. 0.9%, P < 0.001).
Feeding B. infantis EVC001 was well tolerated, and no adverse
events related to probiotic consumption were observed.
Alteration of Microbiome Composition in
Preterm Infants Fed B. infantis EVC001
Shotgun metagenomic sequencing was performed on 292
samples, yielding an average cluster of 33,658,645 (± SD
7,269,047.16) and totaling 67,317,290 (± SD 14,538,094.3)
reads per sample. After quality-filtering and removal of
reads mapping to the human genome using GenCOF (31),
33.6 million sequences per sample (±7.8 million, SD) were
processed for microbial taxonomy and functional classification.
Using a cross-validated clustering approach, three broad
compositional cluster types were identified (Figure 1B; see
Methods). Typical communities in these cluster types were
predominantly composed of either Bifidobacterium longum
species (which includes B. infantis; 56.91%, +/− 20.97% SD),
Escherichia coli (56.14%, +/− 16.00% SD), and unclassified
Escherichia (19.11%, +/− 6.88%), or a more variable mix of
taxa that included Staphylococcus epidermidis (14.22%, +/−
27.51% SD), Klebsiella pneumoniae (23.54% +/− 37.15% SD),
and Enterococcus faecalis (10.73%, +/− 24.86% SD; Figure 1B).
Congruent with the higher sample frequency from infants fed
B. infantis EVC001, the majority of the samples fell into the
high B. longum species cluster type (n = 160), with other
samples split between the Escherichia cluster type (n = 63) and
the more variable cluster type characterized by S. epidermidis
(n = 69). Samples from infants fed B. infantis EVC001 were
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not evenly distributed among the cluster types, with 90% of
samples from the B. longum species cluster having originated
from infants fed B. infantis EVC001, and only 37 and 33%
of samples from the Escherichia species cluster and mixed S.
epidermidis cluster were from infants fed B. infantis EVC001,
respectively. In order to test for the overall diversity between the
three sample clusters and their effect size on the observed clusters,
we ran a permutational multivariate analysis of variance using
distance matrices (adonis) obtained from the sample clustering
analysis. The adonis result by cluster assignment was significant
(P = 0.001), suggesting that the three observed clusters were
different and the effect size of the observed clustering is strong
(R2 = 0.42). Alpha diversity was computed to estimate differences
in microbial community composition in terms of observed
bacterial species and community entropy, using the Shannon
Diversity Index. A linear mixed model was used to account for
clinical and demographic covariates as well as within-subject
variations over time (see Methods). The probiotic-fed group
reported a slightly lower alpha diversity compared to the controls
(P = 0.009; FDR). The complete results of the FDR-adjusted
linear mixed model are reported in Supplemental Table 1,
while individual Shannon diversity indices are reported in
Supplemental Table 2. In order to account for clinical variables
associated with prematurity, and which differed between infants
assigned to each feeding protocol, we used a boosted, additive
linear mixed-effects model (MaAsLin2; https://huttenhower.sph.
harvard.edu/maaslin/) to independently assess the effect that
each of these clinical variables had on the gut microbiome.
When accounting for the individual effect of clinical variables
(i.e., probiotic feeding, inhaled steroid use, diaper rash, recent
antibiotic exposure, diet, total parenteral nutrition (TPN) intake,
age at sampling, weight at birth, gestational age at birth), we
found that while several of them (diaper rash, infant formula in
diet, human milk in diet, age at sampling) did have small, but
significant associations with various bacterial families, the size of
the effect of these clinical variables was quite low when compared
to probiotic feeding (Figure 2A). Notably, the introduction of
B. infantis EVC001, independent of other clinical variables, was
associated with 27.6% more Bifidobacteriaceae abundance, when
all other clinical variables were controlled (FDR-adjusted P value
= 0.000183; Figure 2A). Second, while formula feeding (any
amount) was associated with less Staphylococcaceae (−3.65%,
FDR-adjusted P value = 0.0112), other associations included
age at sampling (day of life), formula feeding, human milk
feeding volume (mL/kg∗day), and diaper rash, all of which were
associated with significant differences in the gut microbiome
(FDR-corrected P < 0.05), but these associations accounted for
less than a 1% change per unit increase (e.g., mL/kg∗day, week, or
day, as indicated; Figure 2A). We also found that delivery mode
had no significant associations with the microbiome, when the
other clinical variables were considered.
As inclusion of feeding B. infantis EVC001 into the
diet of infants had the largest individual impact on gut
microbiome composition (Figure 2A), we also sought to
understand how Bifidobacteriaceae abundance interacted
with other taxonomic groups among infants fed EVC001.
Broadly, increased Bifidobacteriaceae abundance was
strongly associated with diminished Enterobacteriaceae
abundance (which includes the Klebsiella and Escherichia
genera; Spearman’s ρ = −0.85, P < 0.001), and species-
level discrimination confirmed this association between
B. longum species (inclusive of B. infantis) and the most
predominant Enterobacteriaceae species, Escherichia coli, and
Klebsiella pneumoniae, with significant negative correlations
between B. longum species and each of two Enterobacteriaceae
species among infants fed B. infantis EVC001 (respectively,
Spearman’s ρ = −0.38, P < 0.001, Spearman’s ρ = −0.26,
P < 0.001; Figures 2C,D). This was further corroborated by
comparing with species-specific qPCR for B. infantis with
the abundance of these bacteria at different taxonomic levels
(Supplementary Figure 1).
Given that this approach isolates the effect of each clinical
variable on the infant gut microbiome from the others, we
also explored how interactions between clinical variables and
the gut microbiome were further interrelated. B. infantis is
known to utilize human milk oligosaccharides as part of its
colonization of the gut microbiome, so we examined whether
a greater abundance Bifidobacteriaceae was associated with
increased rates of human milk feeding. There was a significant
correlation between the volume of human milk in an infant’s
diet and the abundance of B. longum species (Spearman’s ρ
= 0.26, P < 0.001), but only among infants who had been
fed B. infantis EVC001 (Supplementary Figure 2A). Infants
who were not assigned to the feeding protocol that included
B. infantis EVC001 did not have a significant association
between human milk feeding volume and the abundance of
Bifidobacteriaceae (Supplementary Figure 2B; Spearman’s ρ =
0.046, P = 0.649). The magnitude and relationship between
B. longum species and human milk feeding volume only
among infants fed EVC001 was confirmed by subspecies-
specific qPCR for B. infantis (Spearman’s ρ = 0.34, P < 0.001;
Supplementary Figures 2C,D).
Gut Microbiome Development Is Distinct in
Infants Fed EVC001
As we identified limited impacts of differing clinical variables
between the two feeding cohorts apart from probiotic use and
the associated increased abundance of Bifidobacteriaceae (i.e.,
B. infantis; Figure 2A), which was associated with diminished
abundance of other taxa typical for the preterm infant gut
microbiome (Figures 2B–D), we examined the microbiome
composition of infants in both feeding cohorts over time.
Fecal samples from EVC001-fed infants developed a gut
microbiome distinct from preterm infants not fed a probiotic.
In addition to distinct functional differences, overall taxonomic
composition differed, though a wider range of B. infantis relative
abundances were observed when compared to previous studies
examining the organism in healthy breastfed infants born at
term (27). Taxonomic classification across all samples identified
variable community compositions predominantly composed of
Escherichia [32.59% (+/− 40.00% SD) vs. 9.95% (+/− 23.58%
SD)],Klebsiella [12.09% (+/− 25.61% SD) vs. 22.52% (+/− 28.35
SD)], Bifidobacterium [11.50% (+/− 24.10% SD) vs. 47.50%
(+/− 27.59% SD)], Staphylococcus [11.35% (+/− 27.07% SD)
vs. 3.24% (+/− 9.53%)], Enterobacter [4.64% (+/− 16.28% SD)
vs. 5.25% (+/− 15.72% SD)], and Enterococcus [7.73% (+/−
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FIGURE 2 | Associations between gut taxa and clinical interventions. (A) Heat map describing the output of multivariate analysis of individual clinical variables
(columns) with family-level microbial groups. This approach separates the effects of individual clinical variables and reports the impact of each one, individually, on the
abundance of the given bacterial family (row). Significant associations are indicated by the notation of the FDR-adjusted P value (asterisks), and the degree of the
interaction (coefficient) is indicated by the color scale. Strong, positive associations between a given clinical variable (column) and the bacterial family (row) are
indicated in yellow, while strong negative associations between a clinical variable and a bacterial family are indicated by dark blue. Weak associations (i.e., close to 0)
are indicated in green. Only bacterial families that included a significant association prior to FDR correction are shown. As Bifidobacteriaceae are strongly linked to
probiotic intervention (as indicated by the yellow tile), we examined interactions between this family and its constituents and other bacterial groups among infants fed
B. infantis EVC001. (B) At the family level, Bifidobacteriaceae are strongly negatively correlated with Enterobacteriaceae, as assessed using relative abundance and
Spearman’s rho (ρ), among infants fed B. infantis EVC001. Points are shaded based on the abundance of Bifidobacteriaceae. This is also true for two of the primary
constituents of the Enterobacteriaceae family. (C) E. coli and B. longum species are negatively correlated among infants fed B. infantis EVC001. (D) B. longum is
negatively correlated with K. pneumoniae among infants fed B. infantis EVC001 (FDR-adjusted P values are indicated by asterisks, ****P < 0.0001; ***P < 0.001; **P
< 0.01; *P < 0.05).
17.76% SD) vs. 3.29% (+/− 10.02% SD)] when comparing
samples from infants not fed B. infantis EVC001 to infants fed
the probiotic.
We found that infants fed B. infantis EVC001 typically
developed a high relative abundance of Bifidobacteriaceae,
while infants who were not fed B. infantis EVC001 rarely
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acquired high levels of Bifidobacteriaceae, despite human milk
feeding (Figure 3A). Notably, infants who were <1500 g at
birth were assigned to the feeding protocol which included
B. infantis EVC001 and these infants also developed a high
abundance of B. infantis (Subjects 302 and 335; Figure 3A).
Accordingly, the species cluster identity of samples from infants
fed B. infantis EVC001 were predominantly composed (76%)
of the B. longum species cluster (Figure 3B) and this increased
as infants reached maximum human milk feeding volumes
(33.8 weeks median corrected gestational age) to 81%. In
contrast, samples from infants not fed B. infantis EVC001
were primarily identified as belonging to the Escherichia species
or S. epidermidis species clusters by the time they reached
the maximum human milk feeding volumes (38 and 49%,
respectively, at 36.1 weeks median corrected gestational age),
and this was consistent with the sample identity overall from
infants not fed B. infantis EVC001, representing 40 and 46% of
samples collected from these infants, respectively (Figure 3B).
We corroborated these findings by examining the absolute
abundance of B. infantis via species-specific qPCR (seeMethods).
FIGURE 3 | Infant fecal samples collected over time reflect feeding protocols and improved development trajectories with B. infantis EVC001. (A) Infant fecal samples
(squares) collected over time, arranged by individual patient (y-axis) and corrected gestational age at sample collection, and ordered by gestational age of the infant at
birth (from earliest gestational age at birth, bottom, to oldest gestational age at birth, top) and shaded by the abundance of Bifidobacteriaceae (see color scale). Infant
feeding protocol is denoted by the teal (EVC001-fed) or gray box (No Probiotic). Note that the feeding protocol assignment is based both on gestational age at birth
and birth weight, so some subjects (e.g., 302, 335) were assigned to the probiotic feeding protocol based on weight at birth (i.e., < 1500g). (B) Fecal sample
composition was clustered by species-level signature taxa (e.g., B longum species, Escherichia coli and unclassified Escherichia, and S. epidermidis), as indicated by
color. Infants in the EVC001-fed feeding protocol more frequently developed a gut microbiome composed of primarily B. longum species (blue), while the infants not
assigned to receive the probiotic frequently had compositions typified by high levels of Enterobacteriaceae (e.g., Escherichia species) and/or Staphylococcus (red and
orange, respectively). (C) Over time, infants fed B. infantis EVC001 developed a high mean abundance of Bifidobacteriaceae (blue line) which increased as infants
approached term gestational age, and this was negatively associated with the abundance of Enterobacteriaceae (red line). (D) In contrast, among infants not fed B.
infantis EVC001, the abundance of Enterobacteriaceae did not change as infants approached term gestational age.
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Similar to results obtained by metagenomic sequencing, we
found that among infants fed B. infantis EVC001, B. infantis
levels rapidly increased over time (Supplementary Figure 3) and
reached maximum levels, in terms of both absolute and relative
abundance, as infants approached discharge from the hospital
(Supplementary Figure 3).
B. infantis EVC001 Feeding Improves
Functional Capacity of Preterm Infant Gut
Microbiomes for HMO Utilization
Given that infants in the study population were fed human milk
through 34 weeks cGA or longer, with or without human milk-
based fortification and/or formula, we conducted an exploratory
analysis using the KEGG Orthology (KO) database of functional
orthologs to identify 37 representative key functions necessary
to metabolize human milk oligosaccharides (e.g., oligosaccharide
binding proteins, sialidases, fucosidases, lacto-N biosidase, etc.)
identified by Sela et al. (32) (Figure 4A). We then compared
the distribution of these functions across each of the sample
clusters and examined the impact of B. infantis EVC001-feeding
on the abundance of these functions. A comparative analysis
indicated that the relative amount (counts per million, CPM) of
KO functions related to HMO metabolism was globally enriched
among samples from infants that belonged to the B. longum
species cluster (Figure 4B).
In B. infantis, glycolytic enzymes are internally localized
and require complex HMO-transport systems (e.g., ABC
transporters; green, Figure 4A) to facilitate efficient uptake of
HMO structures into the bacterial cell (33). Functions in this
category were significantly more abundant among samples from
EVC001-fed and from samples belonging to the B. longum-
species cluster (Figures 4B,C). While some Bifidobacterium
species are able to externally degrade carbohydrates and transport
the constituent monomers and dimers [e.g., B. bifidum (34)] and
others are only able to access HMOs by the glycolytic activity
of other bacteria [e.g., B. breve (35)], the mean abundance of
these Bifidobacterium among these samples was very low (1.7%
B. breve, 0.142% B. dentium, and others below 0.01%) and rare
(only three subjects had > 30% B. breve at any time, only
one had > 30% B. dentium). These data emphasized both the
rarity of Bifidobacterium among NICU patients absent probiotic
intervention and the relative importance of the carbohydrate
transport systems to enable HMO utilization by Bifidobacterium
present in these samples.
Among the functions necessary for HMO utilization by the
gut microbiome, glycolytic enzymes including fucosidases and
sialidases are indispensable for the primary removal of terminal
fucose and sialic acid moieties from complex HMO molecules
(blue, Figure 4A). These functions enable degradation of intact
HMO structures into their constituent fragments and the transfer
of these fragments to fermentation pathways (Figure 4A).
Glycolytic functions were significantly enriched among infants
in the B. longum species cluster and among EVC001-fed infants
in other cluster types (teal, Figure 4A) as were key biosynthetic
steps in the cleavage of core I and core II HMO glycans,
lacto-N-biose, and N-acetyllactosamine (e.g., K013509) via sugar
kinases, as well as utilization of sialic acid (e.g., K01788) and
N-acetyl-hexoses (e.g., K15533) (Figure 4C). Together, these
results demonstrate greater primary HMO degradation potential
among infants colonized by B. longum species (Figure 4C), and
particularly, among EVC001-fed infants as all general functions
were significantly enriched (P < 0.0001) among these samples
(Figure 4D).
B. infantis also has genes enabling the transport of urea
and the hydrolysis of urea to ammonia co-localized in the
genome with HMO metabolism (32). As human milk naturally
contains urea (45 µmol/L) (36), the liberation of ammonia
from urea as a nitrogen source has been proposed for B.
infantis (32). Genes involved in urea metabolism (urea transport
and hydrolysis; orange, Figure 4A) were significantly enriched
among samples from infants belonging to the B. longum
species cluster type (Figure 4B), and among EVC001-fed infants
(Figure 4C). Samples from infants that were classified in the
mixed S. epidermidis cluster type were also enriched for
urease transport and activity, relative to the Escherichia species
cluster type. Among the Gram-positive organisms, which were
comparatively enriched among these samples, urease activity is
chiefly thought to be a pH-buffering mechanism (37).
Other functions identified in B. infantis HMO-related gene
clusters which included genes related to regulatory functions
[e.g., a lacI homolog, purple, K02529; and a protein involved in
lysine metabolism (4-hydroxy-tetrahydrodipicolinate synthase),
pink, K01714] were also significantly more abundant (P <
0.0001) among samples from infants in the B. longum species
group and among samples from infants fed B. infantis EVC001
(Figures 4C,D).
Antibiotic Resistance Genes Are Acquired
During NICU Stays and Differ Between
Hospital NICUs
As the spread of antibiotic-resistant bacteria is of particular
concern in clinical practice, we examined the abundance
of antibiotic resistance genes (ARGs) in samples collected
from infants in this study. We first profiled the taxonomic
composition of ARGs in all stool samples (i.e., the resistome).
Nine species were responsible for carrying 86.2% of the total
ARGs identified in the study, while 4.5% of ARGs could not
be confidently assigned to a single species (Figure 5A). The
nine species belonged to the families of Enterobacteriaceae,
Enterococcaceae, and Staphylococcaceae. Escherichia coli harbored
48.5% of the total resistome, followed by Klebsiella pneumonia
(9.6%), Staphylococcus aureus (7.5%), and Enterobacter cloacae
(5.7%). No significant differences in the relative abundance
of bacterial species harboring ARGs were found between the
hospitals studied here (Figure 5A).
Next, we investigated unique ARGs in each NICU and
found that of the 315 genes identified, 204 were common in
both units, while 19 ARGs were specific to Irvine Medical
Center and 92 were specific to the Anaheim Medical
Center (Supplementary Table ARG 3). However, only the
abundance of four ARGs was significantly different when
accounting for sample distribution between hospitals.
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FIGURE 4 | Human milk oligosaccharide (HMO) utilization in B. infantis and the enrichment of HMO-utilizing functions among infants fed B. infantis EVC001. (A)
Bifidobacterium longum subsp. infantis (B. infantis) utilizes a suite of human milk oligosaccharide (HMO)-associated gene loci to transport intact HMO structures into
the cell, where intracellularly located glycosyl hydrolases (blue) break down linkages found commonly among HMO structures. Other enzymes involved in central
(Continued)
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FIGURE 4 | carbohydrate metabolism (teal) are used to convert sugars to the primary metabolic outputs, acetate, and lactate. Other features associated with HMO
utilization include regulatory elements (purple) and urea metabolism (orange). (B) These functions, which are represented as distinct KEGG orthologs, are differentially
abundant among samples, depending on the predominant bacterial species. Samples (columns) with greater abundance (i.e., higher CPM, counts per million) of
HMO-associated KEGG orthology (rows) were found among the B. longum species cluster. (C) All six functional categories were significantly enriched (i.e., greater
CPM) in samples from the B. longum species group (blue box plot), relative to samples composed primarily of S. epidermidis (orange box plot) or Escherichia spp. (red
box plot). This difference is associated with probiotic B. infantis EVC001 feeding (D) as these functional categories were enriched among samples from infants fed
EVC001, relative to samples from infants who were not (P values, adjusted for multiple comparisons, are indicated by asterisks, ****P < 0.0001; ***P < 0.001; **P <
0.01; *P < 0.05). Image created with BioRender.com.
FIGURE 5 | Antibiotic resistant bacteria and antibiotic resistance genes are reduced among infants fed B. infantis EVC001, irrespective of hospital location. (A) The
relative proportion of antibiotic resistance genes identified among taxa in fecal metagenomes. Nearly all ARGs could be assigned to Enterobacteriaceae (red),
Enterococcaceae (yellow), or Staphylococcaceae (green), though some could not be confidently assigned to one organism (purple). (B) Infants transferred between
hospitals participating in this study demonstrated rapid colonization by bacteria harboring hospital-specific ARGs after their transfer date (circle, age in days at
transfer). All four transferred infants were assigned to the feeding protocol including B. infantis EVC001, and the amount of hospital-specific ARGs trended lower and
similar to other infants in the unit that received B. infantis EVC001 (teal line, confidence intervals), relative to infants who did not receive the probiotic (gray line,
confidence intervals). (C) Infants at the two hospitals developed similar patterns of ARG colonization, with more than 100 different unique ARGs detected. Infants
acquired ARGs throughout their stay, though infants fed B. infantis EVC001 tended to acquire fewer unique ARGs (teal), relative to infants who did not receive the
probiotic (gray). (D) Samples from infants fed B. infantis EVC001 also exhibited a lower overall relative abundance of ARGs (teal), as a proportion of their microbiome,
compared to samples from infants who did not receive the probiotic (gray) (P values indicated by asterisks, ****P < 0.0001).
Specifically, the abundance of aadA5 (ARO:3002605), an
aminoglycoside nucleotidyltransferase known to confer
resistance to streptomycin/spectinomycin and encoded by
plasmids, transposons, and integrons in E. coli, K. pneumoniae,
P. aeruginosa, and E. cloacae (38), was significantly more
abundant in the Irvine compared to the Anaheim NICU (P =
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0.01, Bonferroni). The aminoglycoside resistance gene, aph(2”)-
IIIa (ARO:3002636) (39), was also unique to the Irvine Medical
Center. Conversely, the level of gene AAC(6)-Ic (ARO:3002549),
known to confer aminoglycoside resistance in Klebsiella ssp (39),
was significantly more abundant in the Anaheim compared to
Irvine NICU (P = 0.03; Bonferroni). Finally, ARO: 3003291
was the only significantly different ARG found within both
hospitals and was 1.2-fold higher in the Irvine NICU (P = 0.02;
Bonferroni). This gene is known as Staphylococcus aureus
rpoC conferring resistance to daptomycin, a lipopeptide
antibiotic with potent activity against Gram-positive bacteria
(40) (Supplementary Table ARG 3).
While there was not a difference in the taxonomic identity
of ARGs between hospitals, we did identify ARGs specific
to each hospital site (Supplementary Table ARG 3). Four
B. infantis EVC001-fed infants were transferred from the
Anaheim Medical Center to the Irvine Medical Center at
different times throughout the duration of the sample collection
period, and we found all four infants acquired unique, hospital-
specific ARGs after transferring to the new hospital (Figure 5B;
Supplementary Table ARG 4). Importantly, these four infants
were colonized with novel hospital-specific ARGs acquiring 66
new ARGs, on average, in 48 days dependent on NICU length
of stay. Importantly, these four transferred infants reached ARG
levels comparable to infants under the same feeding protocol
including B. infantis EVC001 and maintained fewer ARGs than
infants on the feeding protocol that did not include B. infantis
EVC001 (Figure 5B).
Colonization by B. infantis EVC001 Is
Associated With a Reduced
Antibiotic-Resistant Gene Burden in
Preterm Infants
The mean ARG load (i.e., the resistome) expressed in total
percent composition of the metagenome identified against the
CARD database was 0.04% in the group not fed the probiotic
and 0.008% in the EVC001-fed infants, a difference in mean
ARG abundance of 80.6% (P < 0.0001; Figure 5D). A total
of 315 unique ARGs were identified among all samples from
the CARD database (Supplementary Table ARG 5). Of those, 85
ARGs were differentially abundant between EVC001-fed infants
and those who were not fed probiotics (P < 0.05; Bonferroni).
Eighteen unique ARGs were significantly more abundant in the
EVC001-fed (mean 1.21-fold higher) compared to no probiotic
preterm infants (Supplementary Table ARG 6). Conversely, 67
unique ARGs were significantly more abundant (270-fold higher,
on average) in the no probiotic compared to EVC001-fed
preterm infants. In particular, three ARGs were several orders
of magnitude lower in abundance among the samples from
EVC001-fed infants compared to preterm infants not fed
the probiotic. The gene cat (ARO:3002670) was 104-fold less
abundant (P = 0.005; Bonferroni) in EVC001-fed compared to
infants not fed a probiotic. Cat is a well-known chloramphenicol
acetyltransferase gene described in a range of bacteria including
Enterococcus and Staphylococcus spp. conferring resistance to
phenicol antibiotics (41, 42). Mpha (ARO:3000316) is a gene
that encodes for the resistance enzyme MPH (2’)-I, known to
inactivatemultiple macrolides (e.g., azithromycin, erythromycin)
in species including Enterobacter cloacae, Escherichia coli,
Klebsiella oxytoca, and Klebsiella pneumoniae. Mpha was found
to be 4.6 × 103 fold lower among EVC001-fed compared to
preterm infants not fed the probiotic (P = 0.01; Bonferroni). Of
interest, only 10 preterm infants in the no probiotic group were
known to have received erythromycin during their clinical stay.
Mrx (ARO:3003839, recently updated as ARO:3000333) was 3 ×
103 fold lower in EVC001-fed compared to no probiotic preterm
infants (P = 0.007; Bonferroni). Mrx is also associated with
macrolide resistance and is part of the gene cluster mphA-mrx-
mphR. The majority (70%) of the significant ARGs were classified
as multidrug resistant. Forty-eight multidrug-ARGs were found
to be on average 277-fold lower in EVC001-fed infants when
compared to infants who were not fed the probiotic, which are
known to confer resistance to several drug classes (14 different
drug classes and up to 29 on average).
Finally, given infants in early life acquire microbes from
the environment over time (Figure 5C), we built a mixed-effect
linear model considering time as a function equal to the preterm
infant’s day of life when a sample was collected, respectively,
to assess the rate of nosocomial ARG acquisition. We also
considered whether feeding B. infantis EVC001 or the NICU
location at the time of collection would have an impact on
the model while controlling for individual subject variation.
Our model predicted that with all other variables held constant
in an approximate linear model, infants acquired on average
a new ARG-type for every 2 days spent in the NICU (P <
0.0001). This finding was consistent between hospitals (P> 0.05).
Among preterm infants fed B. infantis EVC001, there were 13.6
fewer ARG types, on average, compared to preterm infants who
were not fed the probiotic throughout their entire NICU stay
(P < 0.05).
Significantly Decreased Enteric
Inflammation in Low Birth Weight
Premature Infants Fed B. infantis EVC001
Compared to Infants Born Closer to Term
at the Same Gestational Age
Inflammatory biomarker production, including cytokines
and calprotectin, drives immunopathogenesis underlying the
increased risk of morbidity and mortality in preterm infants
(43, 44). Given our observational study design comparing
EVC001-fed to no probiotic preterm infants, we first tested
whether longitudinal cytokine and calprotectin concentrations
were associated with clinical metadata or B. infantis EVC001
feeding using a multivariate analysis (Multivariate Analysis
by Linear Models; MaAsLin, n = 245). Here, we showed
that total parenteral nutrition (TPN) usage (mL/kg ∗ day)
significantly associated with increased IL-8 (Figure 6A; 0.07
pg/mL, FDR-adjusted p value, q = 0.018). Conversely, IL-1β
and TNFα production decreased 0.064 and 0.1 pg/mL with
increased TPN usage (mL/kg ∗ day) (Figure 6A; FDR-adjusted
p value, q = 0.018 and 0.018, respectively). Similarly, there
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FIGURE 6 | Proinflammatory biomarkers are significantly lower in preterm infants fed B. infantis EVC001. (A) Multivariate analysis by linear models (MaAsLin2) was
used to assess the effect that each clinical variable had, independently, on proinflammatory biomarker concentrations. Probiotic feeding (B. infantis EVC001) was
significantly associated with lower TNFα concentrations (-1.06 pg/mL per kg per day; FDR-corrected P value = 0.0011). TPN (mL/kg * day) correlated with increased
IL-8 production (1.25 pg/mL per unit increase; FDR-corrected P value = 0.02) and a decrease of IL-1β and TNFα (0.064 and 0.1 pg/mL * day; FDR-corrected P value
= 0.02, 0.02, respectively). Day of life at sampling associated with decreased calprotectin, IL-1β, IL-8, and TNFα production at a rate of 0.04, 0.07, 0.1, and 0.08
pg/mL * day, respectively (FDR-corrected P value = 0.0001, 0.0001, 0.002, and 0.0001, respectively). No significant associations between inhaled steroid exposure,
diaper rash and treatment, antibiotic exposure, formula feeding, human milk consumption, birth weight, or gestational age at birth were identified. (B) Significantly
decreased proinflammatory cytokine, IL-8, correlated with B. infantis EVC001 absolute abundance (P = 0.001, ρ = −0.24). (C) The mean relative abundance of
bacterial families in samples analyzed at the ∼34-week time point, colored by family, is shown. Mean and standard deviations are available in
Supplementary Table 7. (D–I) Box plots represent fecal calprotectin [ug/g] and proinflammatory cytokine concentrations [pg/mg] from infants not fed B. infantis
EVC001 (n = 28) and EVC001-fed infants (n = 29) at 34 weeks corrected gestational age. Calprotectin and cytokine concentrations were measured in duplicate using
MesoScale Discoveries R and U-plex, respectively. Statistical analysis was completed using Wilcoxon rank-sum test. P-values were adjusted using the FDR method
and considered to be statistically significantly decreased if ****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05.
was a weak negative relationship between calprotectin, IL-
1β, IL-8, and TNFα concentration and age (in days) at a
rate of 0.04, 0.07, 0.1, and 0.08 pg/mL per day, respectively
(Figure 6A; FDR-adjusted p value, q = 0.0001, 0.0001, 0.002,
and 0.0001, respectively). Notably, the strongest relationship
was observed between decreased TNFα production with B.
infantis EVC001 inclusion in the feeding protocol (Figure 6A;
−1.06 pg/mL, FDR-adjusted p value, q = 0.01). Inhaled steroid
usage, diaper rash, infant formula exposure, daily probiotic,
birth weight (g), breast milk consumption (mL/kg per day),
antibiotic exposure at sampling, and gestational age at birth
(weeks) were not significantly associated with differences in
cytokine and calprotectin concentrations when all other clinical
variables were considered (Figure 6A). It is important to note
the relationship between TPN and DOL with cytokine and
calprotectin concentrations were weak and the coefficient of
the relationship was below the level of detection for the assay.
Further, we did not find a significant association between delivery
mode and enteric inflammatory biomarkers when other clinical
and demographic variables were considered.
Given the multivariate analysis identified B. infantis EVC001
feeding as the strongest association with decreased enteric
inflammation, we sought to corroborate whether there was an
association of B. infantis EVC001 with cytokine concentrations
(IFNγ, IL-10, IL-13, IL-17A, IL-1β, IL-2, IL-4 IL-5, IL-8, and
TNFα). B. infantis absolute abundance was negatively correlated
with the production of IL-8 (Figure 6B; P = 0.001, ρ =
−0.24) independent of microbiome cluster characterization and
marginally negatively correlated with TNFα, though the latter
was not significant (P = 0.055; ρ =−0.14).
Gut microbiome composition has previously been shown
to modulate the enteric inflammatory markers in term and
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preterm infants (13, 19). Moreover, the hospital feeding protocol
continued feeding of B. infantis EVC001 up to 34 weeks cGA
(see Methods). Given that other clinical differences between the
infants had small or nonsignificant associations with cytokine
production, we next investigated whether EVC001-fed preterm
infants had an altered enteric inflammation profile compared
to no probiotic group at 34 weeks cGA. We selected samples
collected from individual patients in each feeding group as close
as possible to 34 weeks cGA and compared the compositional
changes in the microbiome at this time point between the
EVC001-fed (n = 29; mean cGA 34.1 weeks) and no probiotic
preterm infants (n = 28; mean cGA 35.4 weeks). Among these
samples, the only significantly different bacterial family was
Bifidobacteriaceae, which was more abundant among samples
from B. infantis EVC001-fed infants in this sampling window
(Figure 6C; FDR-corrected P < 0.0001), though the microbiome
composition of the control group was substantially more variable
between subjects (Supplementary Table 7). The composition of
cluster identity of the samples identified in the 34-week cGA
sampling window was significantly different between the two
treatment groups (χ2 P < 0.0001), with far more S. epidermidis
cluster-associated samples among infants who did not receive
the probiotic and more B. longum cluster-associated samples
among infants fed B. infantis EVC001 (Supplementary Table 7).
When considering samples from infants nearest 34 weeks cGA,
significantly lower concentrations of calprotectin, IL-4, IL-5, IL-
8, IL-17A, and TNFα (Figures 6D–I; FDR-corrected P = 0.009,
0.039, 0.026 0.009, 0.032, and 0.009, respectively) were observed
among infants fed B. infantis EVC001 compared to infants not
fed probiotics.
Taken together, these data showed that clinical metadata,
including inhaled steroid use, diaper rash incidence, infant
formula, daily probiotic, birth weight, breast milk consumption,
antibiotic usage, and most importantly gestational age, were
not associated with fecal cytokine or calprotectin concentration.
However, the abundance of B. infantis EVC001, assessed by
subspecies-specific qPCR, correlated with decreased enteric
inflammation. Further, EVC001-fed preterm infants had
significantly lower levels of key proinflammatory biomarkers
compared to samples from infants not fed B. infantis EVC001,
which suggests that colonization of the preterm infant gut
microbiome by B. infantis EVC001 may help modulate enteric
inflammation in premature infants.
DISCUSSION
The gut microbiome plays a major role in the development
of the intestinal mucosa, including maturation of physiological,
anatomical, and biochemical functions in infants (15). The
intestinal microbiome composition and the infant’s response to
these colonizing bacteria are important risk factors for increased
morbidity and mortality, including necrotizing enterocolitis
(NEC) and sepsis in premature infants (24, 30, 45–47). Moreover,
it is evident that premature infants born in hospitalized
environments are colonized by nosocomially acquired bacteria,
including antibiotic-resistant bacteria (6). This increases the
risk of serious infection and death (5) and presents deleterious
implications for preterm infant growth and development (48).
While human milk feeding is an important component of the
current strategy to mitigate these effects, our findings show that
it is insufficient, alone, to prevent colonization by nosocomial
pathogens or diminish the impact of these pathogens on the
enteric immune system (19). Therefore, the importance of early
microbiome development on host health and morbidity and
the relative plasticity of this community presents a need, and
an opportunity, to colonize the preterm gut microbiome with
beneficial organisms thatmaximize ecosystem services to the host
(26). These services include increased availability of nutrients
from human milk, improved maturation of the intestinal
epithelium, reduced enteric inflammation, and mitigated risk
of infection in hospitalized infants (6, 24, 46, 47, 49). In this
study, we found that preterm infants in two hospitals were
colonized by nosocomially acquired bacteria despite a human
milk diet, and the resulting gut microbiomes, absent intervention
with B. infantis EVC001, developed comparably to reports in
the literature on the preterm infant gut microbiome (4, 5, 13).
Early acquisition of skin-derived bacteria (e.g., Staphylococcus
epidermidis) and rapid colonization of the microbiome by
Enterobacteriaceae are consistent with examples of preterm
infant gut microbiome development in the literature (50, 51),
with taxa-dependent implications for preterm infant morbidity
and development (7, 13, 48). Among preterm infants fed
EVC001, we observed that novel microbiome compositions
developed, where colonization by B. infantis resulted in the
displacement of bacteria associated with increased risk of
preterm morbidities (8) (e.g., Figures 2B–D, 3). Moreover,
when preterm infants were fed B. infantis EVC001, their
overall microbiome was significantly enriched in functions
required to access HMOs (32) (Figure 4). This is particularly
relevant because the ability to utilize HMOs as prebiotic
substrates enables B. infantis EVC001 to thrive and modify the
biochemical environment by the production of lactate and acetate
(27). Furthermore, the consumption of HMOs by B. infantis,
an infant-adapted Bifidobacterium, produces critical immune
modulatory metabolites, including indole-3-lactic acid (52). This
functional adaptation to human milk also defines the symbiotic
interaction between B. infantis and the human infant and is
key to the delivery of critical microbiome ecosystem services
important to health and nutrition (26). Epidemiological data
have undeniably demonstrated that breast milk confers benefits
for early and lifelong health to infants (53). However, the infant
also relies on the gut microbiome to fully realize the benefits
from breast milk, especially HMOs. We found that human milk
feeding alone was not able to reduce the abundance of dysbiotic
taxa (e.g., E. coli; Figure 2A). In contrast, our results showed that
feeding B. infantis EVC001 was required to enrich the functions
necessary to harvest additional energy from breast milk and
limit populations of bacteria associated with dysbiosis and poor
growth (e.g., Klebsiella, Enterobacteriaceae) (48) (Figures 2, 3).
Interestingly, we observed that EVC001-fed preterm
infants had significantly less antibiotic exposure (Table 1) and
significantly fewer incidences of diaper rash despite their relative
prematurity at birth, which warrants further investigation
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to understand whether this was directly or indirectly related
to colonization with B. infantis EVC001. Additionally, these
infants had significantly fewer ARGs as a fraction of their
microbiome, with a total reduction in the resistome of 80.6%
compared to the no probiotic group. Specifically, multidrug
resistance genes were, on average, 227-fold higher in infants not
fed a probiotic and some samples had several thousand-fold
higher abundance for specific ARGs compared to EVC001-fed
infants, including Mpha, which confers resistance to macrolide
antibiotics, including erythromycin and azithromycin (54). The
majority of the ARGs identified in this study are known to be
present in potentially pathogenic bacterial species, including
Klebsiella and Enterobacter spp., which are responsible for
nosocomial infections as well as more severe morbidities
including NEC (55, 56) and late-onset sepsis (55, 56). In
addition, we detected unique ARG signatures transferred to
infants and were able to observe the rapid acquisition of site-
specific ARGs, which highlights the NICU environment as a
source of antibiotic resistance microbes that can be transferred
between NICUs (57). We also found that infants acquire these
ARGs throughout their NICU stay, suggesting that reducing
hospitalization times may limit the acquisition of nosocomially
acquired antibiotic-resistant bacteria. Importantly, targeted gut
microbiome modulation using B. infantis EVC001 has now been
shown to be an effective strategy to combat the spread of ARGs
in both term (58) and preterm infants and is unlikely to lead to
the development of novel resistance mechanisms.
Key Bifidobacterium species have been associated with
normal development of immune tolerance, and B. infantis, in
particular, has been shown to normalize the permeability of
the intestinal mucosa (59, 60), which may partially explain why
we saw a significant reduction in enteric cytokine production
similar to previously reported findings in term infants (19).
Indeed, we observed that EVC001-fed preterm infants had
significantly lower enteric inflammation compared to preterm
infants not fed a probiotic, which may be due in part to
the reduction in the abundance of potentially pathogenic
bacteria associated with higher levels of endotoxin (27).
Alternatively, the absolute abundance of B. infantis EVC001,
independent of microbiome composition, correlated with
decreased proinflammatory cytokine profiles, which indicates
a benefit in feeding B. infantis EVC001 and may support
the hypothesis that B. infantis-derived bacterial metabolites,
produced through the utilization of HMOs, induce mucosal
immune tolerance in the gut (52, 61). Notably, Bifidobacterium-
derived acetate has previously been shown to mitigate the
pathogenesis of Enterobacteriaceae infection in an animal model
(60), and B. infantis-derived indole-3-lactic acid production
reduced pathogen-induced inflammation in enterocytes in vitro
(52, 61) through activation of the aryl hydrocarbon receptor
(52, 62). Recently, differences in B. infantis HMO utilization loci
have been identified (63), and strains missing key genes involved
in HMO utilization are unlikely to confer the same benefits to
infants as we observed because they lack the ability to effeciently
convert HMOs to infant accessible short-chain fatty acids and
indole-3-lactic acid, which are key functions of a healthy gut
microbiome, whether in term or preterm infants (26).
There are some limitations to the results presented here,
chiefly by the observational design of the study. Equivalent
longitudinal data sets from both cohorts, those not receiving
probiotics, and those fed B. infantis EVC001 at similar cGAs were
not available with which to compare our findings throughout
the duration of their hospital stays. Given these potential
confounding variables in our data set, we compared the effect
of those differences in clinical variables on the gut microbiome
and cytokine profile usingMaAsLin, between EVC001-fed infants
and infants who were not fed a probiotic (Figures 2A, 6A).
We found that these differences in gestational age or weight
at birth are unlikely to be responsible for the significant
changes we observed between the feeding cohorts, given that
the strongest effect was related to probiotic introduction, and
the abundance of the probiotic organism (i.e., B. infantis) was
linked to: (1) diminished abundance of taxa associated with
preterm neonatal morbidities (Figure 2); (2) with increased
capacity for HMO utilization (Figure 4); (3) with reduced
ARG abundance (Figure 5); and, (4) with diminished enteric
inflammation (Figure 6).
CONCLUSIONS
Overall, the detailed genomic gut microbiome and fecal
inflammatory biomarker observations presented here
demonstrate that the preterm gut microbiome composition
can be altered by feeding B. infantis EVC001. Using multivariate
modeling, we found that independent of clinical variables
associated with degree of prematurity or hospital care, these
changes were uniquely related to feeding B. infantis EVC001
and that this measure had a significant and beneficial impact
on the enteric inflammatory profile. We conclude that the
use of B. infantis EVC001 in conjunction with human milk
in premature infants provides a meaningful and low-risk
approach to alter the gut microbiome composition and increase
the abundance of a well-established infant gut symbiont
that: (1) increased human milk utilization; (2) diminished
enteric inflammation; and (3) decreased the abundance of
taxa associated with antibiotic-resistance and poor health
outcomes (48). Together with human milk feeding, B. infantis
EVC001 may help to mitigate microbiome-associated risk
of morbidity and mortality in hospitalized infants. Future
observational and/or controlled studies examining the impact




This study was performed at Kaiser Orange County Anaheim and
Irvine Neonatal Intensive Care Units (NICUs) under oversight
from the Institutional Review Board Kaiser Permanente Southern
California (IRB # 12079). Eligible preterm infants were enrolled
during the period ofMay 2019 to October 2019. Inclusion criteria
included premature birth < 39 weeks corrected gestational age
(cGA) or <1500 grams. Infants born <32 weeks cGA were fed
B. infantis EVC001 8 × 109 CFU in MCT oil up until 34 cGA
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as per the standard of care feeding protocol Kaiser Permanente
Southern California. At the time of stool collection, site personnel
recorded data about the infants and the stool samples and this
information was cross-verified by independent hospital staff
by comparing de-identified subject and sample metadata from
electronic medical records. Data collected from collection logs
and electronic medical records included antibiotic exposure on
collection days, stool type (meconium, non-meconium, mixed),
subject’s gestational age at birth, corrected gestational age at
sample collection, subject’s intake of probiotics, medication, and
subject’s current diet (i.e., human milk and/or infant formula).
Stool samples tubes and stool collection log entry was tagged
with linked barcoded labels by the study personnel. Fecal samples
were collected from the diaper by site personnel, transferred into
sterile collection tubes, and immediately frozen in a designated
freezer (-20◦C) inside the NICU. Stool samples were collected
weekly and shipped on dry ice to the laboratory where they were
aliquoted and stored at −80◦C for subsequent analysis. A total
of 298 fecal samples from 77 premature infants throughout 26–
40 weeks corrected gestational age were collected from Anaheim
and Irvine NICUs.
Bacterial DNA Methods
Sufficient DNA was extracted from 296 stool sample aliquots
stored in DNA/RNA shield lysis tubes (Zymo Research, Irvine
CA) using the ZymoBIOMICS 96 MagBead DNA kit (Zymo
Research). Extracted DNA was quantified using QuantIT dsDNA
Assay kit, high sensitivity (Thermo Fisher Scientific, Waltham,
MA) according to the manufacturer’s protocol. Three (3) samples
were omitted from downstream analysis due to failure to
meet input requirements for library preparation. Libraries were
prepared for each sample using the Illumina Nextera DNA Flex
library kit (Illumina, San Diego, CA) with unique dual indexes
according to manufacturer guidelines. Libraries were pooled and
submitted to UC Davis DNA Technologies Core for sequencing
on an Illumina NovaSeq S4 flow cell (Illumina, San Diego, CA).
Each lane of the S4 flow cell contained 96 libraries.
Absolute Quantification of B. infantis by
Quantitative Real-Time PCR
Quantification of the total B. infantis was performed by
quantitative real-time PCR using Blon_2348 sialidase gene
primers Inf2348F (5′-ATA CAG CAG AAC CTT GGC CT-
3′), Inf2348_R (5′-GCG ATC ACA TGG ACG AGA AC-3′),
and Inf2348_P (5′-/56-FAM/TTT CAC GGA /ZEN/TCA CCG
GAC CAT ACG /3lABkFQ/-3′) (64). Each reaction contained 10
µL of 2× TaqMan Universal Master Mix II with UNG master
mix (Thermo Fisher Scientific, Waltham, MA), 0.9µM of each
primer, 0.25µM probe, and 5 µL of template DNA. Thermal
cycling was performed on a QuantStudio 3 Real-Time PCR
System and consisted of an initial UNG activation step of 2min
at 50◦C followed by a 10-min denaturation at 95◦C, succeeded
by 40 cycles of 15 s at 95◦C and 1min at 60◦C. Standard curves
for absolute quantification were generated using genomic DNA
extracted from a pure culture of B. infantis EVC001.
Quality Filtering and Removal of Human
Sequences
Demultiplexed fastq sequences were quality filtered, including
adaptor trimming using Trimmomatic v0.36 (65) with
default parameters. Quality-filtered sequences were screened
to remove human sequences using GenCoF v1.0 (31)
against a nonredundant version of the Genome Reference
Consortium Human Build 38, patch release 7 (GRCh38_p7;
www.ncbi.nlm.nih.gov).
Taxonomic and Strain Profiling
Taxonomic profiling of the metagenomic samples was performed
using MetaPhlAn2 (66), which uses a library of clade-specific
markers to provide pan microbial (bacterial, archaeal, viral,
and eukaryotic) profiling (http://hutten-hower.sph.harvard.edu/
metaphlan2), in combination with Humann2 (67) to profile
functional metagenomics against Uniref90 following the updated
global profiling of the Human Microbiome Project (2017)
(68). Cross-database annotations (e.g., UniProt to KEGG)
were performed within Humman2 using the “utility_mapping”
conversion tool package.
Taxonomic Cluster Grouping Assignment
Species-level taxonomic data consisting of 218 species relative
abundance across 292 samples and 77 subjects was used for
the analysis. Following the methodology from a previously
published study (69), samples were clustered using Jensen–
Shannon Divergence (JSD) distance and the Partitioning Around
Mediods clustering algorithm. The results were assessed for the
optimal number of clusters using the Calinski–Harabasz (CH)
Index and Silhouette coefficient. Clustering performed on the
full dataset did not show a clear optimal number of clusters.
Additionally, uneven sampling between subjects could led to
cluster formation dominated by one or a few subjects with a high
number of samples. Because of these concerns, subset datasets
were created by randomly selecting one sample per subject 1,000
times. Each of the subset datasets were clustered with the same
methodology as the full dataset. CH index was computed for
iterations from 2 to 6 clusters within each subset. The maximum
of those values was chosen as the optimal number of clusters
for that subset. Maximum CH index coefficients were stored and
observed after the 1,000 cluster iterations and, again, did not
show a clear choice for an optimal number of clusters.
Instead, between-class analysis (BCA) was used to identify
drivers for clusters. The top n important species (where n =
twice the number of clusters) were saved for each iteration.
Top important taxa were then associated with a specific cluster
by examining the angle of importance with the angle of the
cluster median on the first two component axes. If the angle
was within ±22.5 degrees, that species was considered to be
associated with that cluster. Any species shown as both important
and associated with a specific cluster at least 800 times over the
1000 iterations was considered a primary driver. Four species
(E. coli, unclassified Escherichia species, B. longum species, and
S epidermidis) met these criteria. Enterotyping of subset datasets
proved challenging and inconclusive; therefore, these datasets
were further restricted to include only the top cluster-driving
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bacteria. The CH index and silhouette were examined on the
species-restricted datasets, and both metrics pointed to 3 as the
optimal number of clusters. BCA was performed again on the
species-restricted data and showed a pattern of B. longum species,
S. epidermidis, and E. coli/unclassified Escherichia clusters. The
cluster that each sample fell in over the 1000 iterations was
examined. Most samples fell within the same species-driven
cluster 100% of the time, and all samples fell within the same
cluster at least 90% of the time. Confident that this method
of clustering was robust, each sample was then assigned to
the cluster it fell into most frequently. The overall diversity
between the three observed clusters and the size of the difference
between the sample clusters were tested using a permutational
multivariate analysis of variance using distance matrices (adonis)
obtained from the taxonomic cluster analysis. Alpha diversity
was computed at the species level using the Shannon diversity
index metric. A linear mixed model was performed in R v.1.1.453
using the package “lme4.” The Shannon diversity indices were
used as input to the linear mixed model and compared to several
fixed covariates including, whether or not the infants received
the probiotic, the age in days postnatal (day of life), and the
species cluster assignment, while subject identity was used as a
random variable to account for individual variations. P values
were adjusted using an FDR correction.
Antibiotic Resistance Gene Analysis
We applied ShortBRED (70, 71) to profile antibiotic resistance
(AR) abundance and composition in the infant gut microbiome.
We first produced a set of new AR marker sequences by applying
ShortBRED-Identify to the Comprehensive Antibiotic Resistance
Database (CARD) (72). We then used ShortBRED-Quantify
to profile the relative abundance of corresponding antibiotic
resistance genes (ARGs). Final values were normalized in Reads
Per Kilobase per Million mapped reads (RPKM) to account for
sequencing depth as well as gene length. We used custom scripts
to collapse CARD individual antibiotic resistance gene entries
in their corresponding drug class. Conversion rules are offered
within every CARD package update.
Multiplexed Immunoassays
Interleukin (IL)-1 β, IL-2, IL-4 IL-5, IL-8, IL-10, IL-13, IL-
17A, interferon (IFN) γ, and tumor necrosis factor (TNF) α
were quantified from 80mg of frozen stool diluted 1:10 in
Meso Scale Discovery (MSD; Rockville, MD) diluent using
the U-PLEX Inflammation Panel 1 (human) Kit, and the
concentration of fecal calprotectin was quantified using MSD R-
PLEX Human Calprotectin Antibody Set. Standards and samples
were measured in duplicate, and blank values were subtracted
from all readings according to the manufacturer’s instructions
as previously published (19). All detectable biomarker values
were included as continuous data in the analyses; however,
values below level of detection (< 30% of all cytokines
and calprotectin measurements) were generated below the
level of quantification to justify parametric statistics. Fecal
cytokine and calprotectin concentrations were determined
using calibrations curves to which electrochemiluminescence
signals were backfitted. Final concentrations were calculated
using the Sector Imager 2400 MSD Discovery Workbench
analysis software.
Statistical Analysis
Statistical analyses were performed in R v3.6.2. A Kruskal–
Wallis one-way analysis of variance coupled with an FDR
or Bonferroni correction was used for statistical comparisons
between gene groups, cytokines, and taxa among groups. A post
hoc Dunn test was applied to determine differences between-
species clusters. Statistical analysis to assess total resistome or
taxonomic composition by group was performed using a Mann–
Whitney or Holm-adjusted Dunn’s test. Rarefaction curves were
computed to estimate the diversity of the identified ARGs
across samples. A nonparametric two-sample t-test was used to
compare rarefaction curves using Monte Carlo permutations (n
= 999). To test for the association of microbial abundance with
clinical metadata, we performed a multivariate analysis using
Multivariate Analysis by Linear Models (MaAsLin2) version for
R. Maaslin2 performs boosted, additive general linear models
between metadata and microbial abundance (at the taxa level).
Boosting of metadata and selection of a model was performed
per taxon and, separately, per inflammatory biomarker. The
metadata used were total parenteral nutrition (TPN; mL/kg
per day), inhaled steroid use associated with sample collection,
diaper rash treatment/incidence (e.g., desitin), gestational age
at birth (GA, in weeks), formula use associated with sampling,
age in days (day of life, DOL), probiotic feeding protocol
(EVC001-fed or no probiotic), birth weight (grams), human
milk consumption (mL/kg per day), and antibiotic exposure
associated with sampling. A linear mixed-effects model was used
to examine the effects of probiotic use on ARG acquisition.
ARG counts per sample were modeled with probiotic use, day
of life, and hospital as fixed effects and hospital and subject
as random effects. For random effects, we also examined the
degree to which the hospital effect on a given subject deviates
from the global effect of hospital. χ2 tests were used to compare
species cluster compositions between groups, where indicated.
Cytokines and B. infantis-specific qPCR were correlated with the
Spearman method with FDR correction. P values throughout the
manuscript are represented by asterisks (∗∗∗∗P < 0.0001; ∗∗∗P <
0.001; ∗∗P < 0.01; ∗P < 0.05).
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Supplementary Fig 1. B. infantis abundance is negatively correlated with 
taxa commonly associated with neonatal morbidities. Confirmation of B. 
infantis abundance, as determined by subspecies-specific qPCR correlations 
with (A) Enterobacteriaceae among samples from infants in each feeding cohort, 
shaded by the relative abundance of Bifidobacteriaceae,  (B) Levels of B. 
infantis and the correlation with Escherichia coli, shaded by B. longum 
abundance and (C) the abundance of Klebsiella pneumoniae, shaded by B. 
longum species abundance. Spearman correlation values are shown, with the 
linear trend displayed.
Supplementary Fig 2. B. infantis abundance is associated with human milk 
feeding. Bifidobacterium longum species abundance (Panel A) is significantly 
correlated with the rate of human milk feeding (y-axis) among infants fed B. 
infantis EVC001, but not among infants who were not fed the probiotic (Panel 
B). This was corroborated by subspecies-specific qPCR for B. infantis (Panel 
C,D) which found the same correlation trends. Points are shaded by the 
abundance of B. longum species in the samples. Spearman correlation values 
are shown, with the linear trend displayed.
Supplementary Fig 3. B. infantis abundance increases after probiotic 
feeding. qPCR using a B. infantis subspecies-specific assay demonstrates an 
increase in the abundance of B. infantis among infants fed the probiotic B 
infantis EVC001 (teal trend line and shaded confidence interval), but not among 
infants who were not (grey trend line and shaded confidence interval). Samples 
are shaded by the abundance of B. longum (relative abundance, %) in each 
sample, corroborating the increase in B. longum species is driven by the 
abundance of B. infantis in the sample.
